Overview

* Owens & Minor ( OMI ) misses analysts' expectations for Q3 revenue

* However, adjusted EBITDA beats consensus

* Company shifts focus to home-based care, with sale of Products & Healthcare Services

Outlook

* Company reaffirms 2025 revenue guidance of $2.76 bln to $2.82 bln

* Owens & Minor ( OMI ) maintains 2025 adjusted EPS guidance of $1.02 to $1.07

* Company expects 2025 adjusted EBITDA between $376 mln and $382 mln

Result Drivers

* STRATEGIC SHIFT - Owens & Minor's ( OMI ) sale of Products & Healthcare Services segment aligns with focus on home-based care, per CEO Edward A. Pesicka

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $697.30 $1.13

Revenue mln bln (5

Analysts

)

Q3 Net -$150.27

Income mln

Q3 Beat $92.20 $91.59

Adjusted mln mln (5

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

* Wall Street's median 12-month price target for Owens & Minor Inc ( OMI ) is $6.50, about 19.7% above its October 29 closing price of $5.22

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)